Integrating Genetic Variants and Expression Profiles of Pharmacogenes to Investigate Resistance to Antidepressant Treatment. [PDF]
Pisanu C +19 more
europepmc +1 more source
The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke. [PDF]
Deiman B +4 more
europepmc +1 more source
Toxicokinetic Studies of the Two Stimulants M-ALPHA and <i>N</i>-Methyl-cyclazodone Using In Vitro and In Vivo Tools. [PDF]
Gampfer TM +3 more
europepmc +1 more source
Vietnamese pharmacogenomic variation in global context: a systematic review and meta-analysis for clinical implementation. [PDF]
Hoang VTB +6 more
europepmc +1 more source
Dexamethasone-Mediated Regulation of CYP3A4 and UGTs in Human Hepatoma HuH-7 Cells. [PDF]
Yu H, Lee SH, Kim JH, Kim SJ, Kang HE.
europepmc +1 more source
Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe. [PDF]
Mazhindu TA +5 more
europepmc +1 more source
Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use. [PDF]
Baune BT.
europepmc +1 more source
Roadmap for Mental Health Treatment Utilizing Pharmacogenomic Testing: Case Report. [PDF]
Swanson AP, Mewborn EK, Bae G.
europepmc +1 more source
SINEUP-mediated enhancement of HNF4α improves metabolic function in Huh7-based bioengineered hepatic microtissues. [PDF]
Hashemian Z +8 more
europepmc +1 more source
Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions. [PDF]
Smatti MK, Jan Z, Yassine HM.
europepmc +1 more source

